More Than Just Reproductive Health
The Women’s Health space is moving towards concentrating on the overall well-being of women throughout their entire life cycle, rather than their reproductive needs alone. Postmenopausal conditions, including Vulvovaginal Atrophy, that affect a woman’s quality of life are actively being fostered for innovation of new therapies and dosage forms. With the rapid growth of this therapeutic area, the competition to enter onto the market quickly is equally as present. This quickness can be hindered by restricting I/E criteria and variable endpoints. Unforeseen factors like these can lead to unexpected complications when running Women’s Health trials.
Treating Women’s Health Holistically
Biorasi’s history in successfully running women’s health trials covers the full spectrum of women’s lives. This experience allows Biorasi to identify and proactively mitigate any anticipated challenges, and include one of the many board certified OBGYNs in our site network for successful study completion. Biorasi is capable and ready to provide your next women’s health study with the time, attention, and tailored solutions it deserves.
"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."VP of Global Clinical Development, Top Specialty Pharma
Latest News and Blogs
The liver does many important things in the body, such as filtering of the blood and metabolizing all compounds, including food and drugs, that enter the body. In that vein, liver disease can be absolutely devastating. Non-alcoholic fatty liver disease (NAFLD)...
Earlier this year, a few of us attended DIA 2018 to represent Biorasi. While there, we were fortunate enough to be able to give a talk about some of our experiences entitled “Balancing Unity and Individuality: Leadership Skills for Managing Culturally Divergent...